Skip to main content
. 2023 Mar 28;13(4):898. doi: 10.3390/life13040898

Table 2.

Concentration of syndecan-1 and classical biomarkers in patients with acute and chronic HF.

Biomarker Patient Group No. Median (IQR:25–75) p-Value
Syndecan-1 (ng/mL) Acute HF 120 121.4 (69.3–257.9) 0.015
Control group 53 72.1 (41.4–135.8)
NT-proBNP
(pg/mL)
Acute HF 120 5440 (2812–12791) <0.01
Control group 53 107.8 (41.3–325.2)
High-sensitive Troponin
(ng/L)
Acute HF 120 40.1 (12.4–179.5) <0.01
Control group 53 2.2 (1.1–5.4)